Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.

von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association w...

Full description

Bibliographic Details
Main Authors: Eric Manderstedt, Christina Lind-Halldén, Stefan Lethagen, Christer Halldén
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5794141?pdf=render
_version_ 1811201398637854720
author Eric Manderstedt
Christina Lind-Halldén
Stefan Lethagen
Christer Halldén
author_facet Eric Manderstedt
Christina Lind-Halldén
Stefan Lethagen
Christer Halldén
author_sort Eric Manderstedt
collection DOAJ
description von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association with type 1 VWD in the Swedish population. In order to screen for CLEC4M variants, the CLEC4M gene region was re-sequenced and the polymorphic neck region was genotyped in 106 type 1 VWD patients from unrelated type 1 VWD families. Single nucleotide variants (SNV) and variable number tandem repeat (VNTR) allele and genotype frequencies were then compared with 294 individuals from the 1000Genomes project and 436 Swedish control individuals. Re-sequencing identified a total of 42 SNVs. Rare variants showed no accumulation in type 1 VWD patients and are not thought to contribute substantially to type 1 VWD. The only missense mutation (rs2277998, NP_001138379.1:p.Asp224Asn) had a higher frequency in type 1 VWD patients than in controls (4.9%). The VNTR genotypes 57 and 67 were observed at higher frequencies than expected in type 1 VWD patients (6.4% and 6.2%) and showed an increase in patients compared with controls (7.4% and 3.1%). Strong linkage disequilibrium in the CLEC4M region makes it difficult to distinguish between the effect of the missense mutation and the VNTR genotypes. In conclusion, heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population.
first_indexed 2024-04-12T02:21:16Z
format Article
id doaj.art-812583975df54516b855f618980ff53b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T02:21:16Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-812583975df54516b855f618980ff53b2022-12-22T03:52:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019202410.1371/journal.pone.0192024Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.Eric ManderstedtChristina Lind-HalldénStefan LethagenChrister Halldénvon Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, e.g. VWF, ABO, STXBP5 and CLEC4M. This study aims to screen comprehensively for CLEC4M variants and investigate their association with type 1 VWD in the Swedish population. In order to screen for CLEC4M variants, the CLEC4M gene region was re-sequenced and the polymorphic neck region was genotyped in 106 type 1 VWD patients from unrelated type 1 VWD families. Single nucleotide variants (SNV) and variable number tandem repeat (VNTR) allele and genotype frequencies were then compared with 294 individuals from the 1000Genomes project and 436 Swedish control individuals. Re-sequencing identified a total of 42 SNVs. Rare variants showed no accumulation in type 1 VWD patients and are not thought to contribute substantially to type 1 VWD. The only missense mutation (rs2277998, NP_001138379.1:p.Asp224Asn) had a higher frequency in type 1 VWD patients than in controls (4.9%). The VNTR genotypes 57 and 67 were observed at higher frequencies than expected in type 1 VWD patients (6.4% and 6.2%) and showed an increase in patients compared with controls (7.4% and 3.1%). Strong linkage disequilibrium in the CLEC4M region makes it difficult to distinguish between the effect of the missense mutation and the VNTR genotypes. In conclusion, heterozygous VNTR genotypes 57 and 67 of CLEC4M were highly enriched and are the most likely mechanism through which CLEC4M contributes to disease in the Swedish type 1 VWD population.http://europepmc.org/articles/PMC5794141?pdf=render
spellingShingle Eric Manderstedt
Christina Lind-Halldén
Stefan Lethagen
Christer Halldén
Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
PLoS ONE
title Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
title_full Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
title_fullStr Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
title_full_unstemmed Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
title_short Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
title_sort genetic variation in the c type lectin receptor clec4m in type 1 von willebrand disease patients
url http://europepmc.org/articles/PMC5794141?pdf=render
work_keys_str_mv AT ericmanderstedt geneticvariationinthectypelectinreceptorclec4mintype1vonwillebranddiseasepatients
AT christinalindhallden geneticvariationinthectypelectinreceptorclec4mintype1vonwillebranddiseasepatients
AT stefanlethagen geneticvariationinthectypelectinreceptorclec4mintype1vonwillebranddiseasepatients
AT christerhallden geneticvariationinthectypelectinreceptorclec4mintype1vonwillebranddiseasepatients